Vascular endothelial tyrosine phosphatase (VE-PTP)-null mice undergo vasculogenesis but die embryonically because of defects in angiogenesis
about
Paladin (X99384) is expressed in the vasculature and shifts from endothelial to vascular smooth muscle cells during mouse developmentVE-PTP controls blood vessel development by balancing Tie-2 activityNew Insights into VacA Intoxication Mediated through Its Cell Surface ReceptorsRegulation of Endothelial Adherens Junctions by Tyrosine PhosphorylationSmall molecule tools for functional interrogation of protein tyrosine phosphatasesVe-ptp modulates vascular integrity by promoting adherens junction maturationStable vascular connections and remodeling require full expression of VE-cadherin in zebrafish embryos.Angiopoietin-Tie signalling in the cardiovascular and lymphatic systemsAW551984: a novel regulator of cardiomyogenesis in pluripotent embryonic cellsVE-PTP regulates VEGFR2 activity in stalk cells to establish endothelial cell polarity and lumen formationRecurrent PTPRB and PLCG1 mutations in angiosarcoma.Expression of receptor-type protein tyrosine phosphatase in developing and adult renal vasculatureAn ENU-mutagenesis screen in the mouse: identification of novel developmental gene functions.Endothelial Akt1 mediates angiogenesis by phosphorylating multiple angiogenic substrates.A general chemical method to regulate protein stability in the mammalian central nervous systemVEGF-mediated fusion in the generation of uniluminal vascular spheroidsTargeting VE-PTP activates TIE2 and stabilizes the ocular vasculatureMitogen-activated protein kinase phosphatase-1 is a key regulator of hypoxia-induced vascular endothelial growth factor expression and vessel density in lungReceptor-type protein tyrosine phosphatase beta (RPTP-beta) directly dephosphorylates and regulates hepatocyte growth factor receptor (HGFR/Met) function.Hydroxyindole carboxylic acid-based inhibitors for receptor-type protein tyrosine protein phosphatase betaPrdm6 is essential for cardiovascular development in vivoThe angiopoietin-Tie2 signaling axis in the vascular leakage of systemic inflammationThe complex role of angiopoietin-2 in the angiopoietin-tie signaling pathway.Interfering with VE-PTP stabilizes endothelial junctions in vivo via Tie-2 in the absence of VE-cadherin.The phosphatase PTP-PEST/PTPN12 regulates endothelial cell migration and adhesion, but not permeability, and controls vascular development and embryonic viabilityDeficiency of zonula occludens-1 causes embryonic lethal phenotype associated with defected yolk sac angiogenesis and apoptosis of embryonic cellsHypoxia-induced expression of VE-cadherin and filamin B in glioma cell cultures and pseudopalisade structuresSWI/SNF chromatin-remodeling factor Smarcd3/Baf60c controls epithelial-mesenchymal transition by inducing Wnt5a signalingProtein tyrosine phosphatases: functional inferences from mouse models and human diseases.Effects of vascular-endothelial protein tyrosine phosphatase inhibition on breast cancer vasculature and metastatic progressionFrom germline towards somatic mutations in the pathophysiology of vascular anomalies.Microbial induction of vascular pathology in the CNS.Apical junction complex proteins and ulcerative colitis: a focus on the PTPRS gene.Deciphering the functional role of endothelial junctions by using in vivo modelsLack of TEK Gene Mutation in Patients with Cutaneomucosal Venous Malformations from the North-Western Region of Algeria.Embryonic stem cell tumor model reveals role of vascular endothelial receptor tyrosine phosphatase in regulating Tie2 pathway in tumor angiogenesis.Shear stress-induced redistribution of vascular endothelial-protein-tyrosine phosphatase (VE-PTP) in endothelial cells and its role in cell elongation.Dual roles of protein tyrosine phosphatase kappa in coordinating angiogenesis induced by pro-angiogenic factors.VE-cadherin: at the front, center, and sides of endothelial cell organization and function.Endothelial cell-to-cell junctions: adhesion and signaling in physiology and pathology.
P2860
Q24305564-8E0E8A1D-1F29-4DA5-A9A6-6BFD9F29BC50Q24311848-0282CFCD-C515-4822-BD6A-FE00D2103BA7Q26748950-0AC4BF0C-94C6-40AB-A349-F6B48505D489Q26778080-A95AD8FE-906A-4B5A-AE78-A61734FC0A9BQ26852276-0F499E40-250D-426E-9A70-127EAB96A09EQ27332101-3E18120B-311A-4B66-8A7A-172E6CF78D43Q27348907-FA48FC5B-D8B7-4B89-9974-8F4FB7243D9CQ28070234-FC6B5EF5-D972-46BB-B883-12DAE45E660CQ28587426-9493CE3D-E6E2-4B26-B34C-372553C0EA10Q30539522-4AF3B480-681E-4F58-BA86-8A7DB1CCE513Q33657848-DC111A79-BF78-4A1F-B7F3-2C0E8B32E1F9Q33727920-B67C417F-0EB0-4245-BC9A-4B78D7151362Q33895030-094038AA-907B-415D-BF87-4123A54B1925Q34144300-5F2AFD11-573A-4445-948C-F7BC5BE906FDQ34145670-499E7757-5DA5-418F-B664-C9FC30E217FFQ34150126-9C720C47-741B-4CA3-BAA7-A96FE6E2073DQ34311551-239CDD19-F924-4E90-9611-C3F8B7FA75B6Q34756182-44D17EAE-24F5-41D2-A4BE-7FA50E195B8EQ34963286-7DF5FD0A-7C23-45DD-883B-F8937CF4A165Q35030333-6CB1E801-9EA3-4C61-BFDD-56C2637B364EQ35054101-206087C5-CFA6-4722-9101-2E97B8C7C978Q35212821-E475CE38-4980-4C4D-98D7-617B708C78F0Q36186523-5A239540-3ABC-4BC6-A642-1C9B80C0E4C3Q36398774-17C87D56-07E3-427F-B6A6-49B176991251Q36466850-6BBAEF9A-B07A-4AC0-A011-4C8F35838EBEQ36678082-3185EA70-CBEE-48FF-916B-373D6E6628FBQ36849835-8F638858-FD24-49DB-8B1B-B9AF2D7D0BB9Q37036337-84F9AE31-2CEE-4B58-8BF3-A91D6C6355EBQ37094061-97738426-67DC-4E69-8A02-968B3C2E3CD1Q37106787-CB71C44F-F834-4374-86A5-A5C11754B36FQ37134125-BE3D1D9C-C6E4-4992-8CB2-A65104603A8AQ37184157-F56B926B-03E6-417A-8454-AF780B91C9F2Q37206258-100EA5A0-1F99-4BB2-A2AD-D547D33A4696Q37207003-379E0143-2652-4B5F-89A9-F3B6D1022587Q37412683-33B1E246-9DC6-4AE5-92EF-11990D4D011EQ37477150-08EA96C8-9E50-4D6D-94E6-AE297AFE2549Q37622536-425A9DAB-A0EA-400C-BE73-A5EA329407CEQ37718673-AC5F909C-9166-46AC-AE66-502971E40E6CQ37779858-046681AE-ECDA-43EE-8B8A-0E84724F6BFFQ38048760-AD18265B-D5CC-4E87-9D15-B4BFB2E2526D
P2860
Vascular endothelial tyrosine phosphatase (VE-PTP)-null mice undergo vasculogenesis but die embryonically because of defects in angiogenesis
description
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
article publié dans les Procee ...... f the United States of America
@fr
artículu científicu espublizáu en 2007
@ast
im Februar 2007 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2007/02/27)
@sk
vědecký článek publikovaný v roce 2007
@cs
wetenschappelijk artikel (gepubliceerd op 2007/02/27)
@nl
наукова стаття, опублікована в лютому 2007
@uk
name
Vascular endothelial tyrosine ...... use of defects in angiogenesis
@ast
Vascular endothelial tyrosine ...... use of defects in angiogenesis
@en
Vascular endothelial tyrosine ...... use of defects in angiogenesis
@nl
type
label
Vascular endothelial tyrosine ...... use of defects in angiogenesis
@ast
Vascular endothelial tyrosine ...... use of defects in angiogenesis
@en
Vascular endothelial tyrosine ...... use of defects in angiogenesis
@nl
prefLabel
Vascular endothelial tyrosine ...... use of defects in angiogenesis
@ast
Vascular endothelial tyrosine ...... use of defects in angiogenesis
@en
Vascular endothelial tyrosine ...... use of defects in angiogenesis
@nl
P2093
P2860
P3181
P356
P1476
Vascular endothelial tyrosine ...... use of defects in angiogenesis
@en
P2093
Christopher Daly
David M Valenzuela
Gavin Thurston
George D Yancopoulos
Irene Noguera-Troise
Keith Anderson
Mary Simmons
Melissa G Dominguez
Nicholas W Gale
P2860
P304
P3181
P356
10.1073/PNAS.0611510104
P407
P577
2007-02-21T00:00:00Z